Cargando…

Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer

Background: Obesity is associated with poor prognosis in breast cancer patients. This study aimed to evaluate the effect of obesity measured by body mass index (BMI) on survival of Taiwanese breast cancer patients in a single institution. Methods: We observed 5000 patients who were diagnosed with st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yung-Chang, Cheng, Hsiao-Hsiang, Chen, Shin-Cheh, Shen, Wen-Chi, Huang, Yi-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210548/
https://www.ncbi.nlm.nih.gov/pubmed/34149912
http://dx.doi.org/10.7150/jca.59133
_version_ 1783709333574385664
author Lin, Yung-Chang
Cheng, Hsiao-Hsiang
Chen, Shin-Cheh
Shen, Wen-Chi
Huang, Yi-Ting
author_facet Lin, Yung-Chang
Cheng, Hsiao-Hsiang
Chen, Shin-Cheh
Shen, Wen-Chi
Huang, Yi-Ting
author_sort Lin, Yung-Chang
collection PubMed
description Background: Obesity is associated with poor prognosis in breast cancer patients. This study aimed to evaluate the effect of obesity measured by body mass index (BMI) on survival of Taiwanese breast cancer patients in a single institution. Methods: We observed 5000 patients who were diagnosed with stage I-III breast cancer between 1990 and 2005. Information on BMI at diagnosis, and clinical follow-up for disease recurrence and death, up to 20 years post-diagnosis were available. BMI (in kg/m(2)) categories included normal weight (BMI<24), overweight (24≤BMI<27), and obesity (BMI≥27), according to recommendations from the Bureau of Health Promotion of Taiwan. The role of BMI and other known prognostic factors for patient survival were evaluated in this patient cohort. Results: Obesity was associated with advanced stage, higher nuclear grade, and higher percentages of estrogen receptor (ER) positive. The median age of patients with a higher BMI was greater than the median age of patients with a lower BMI. Obesity was an independent prognostic factor of overall survival (OS) (P<0.001), but not disease-free survival (DFS) (P=0.067). We subsequently analyzed the impact of age-stratified BMI (age<50 and age≥50 years) to ameliorate the impact of age bias. Following subset analyses, obesity correlated with shorter DFS (P=0.004) and OS (P=0.009) only in women<50 years of age. Multivariate analysis revealed that BMI was an independent prognostic factor for both DFS and OS in this group of patients. Subset analysis revealed that in women <50 years old, the impact of BMI on survival was associated with higher stage, ER negativity. Conclusion: BMI is an independent prognostic factor of OS and DFS in breast cancer patients aged<50 years. Although the cause-effect relationship between obesity and survival is unclear, we recommend that weight control measures in young breast cancer survivors should be considered.
format Online
Article
Text
id pubmed-8210548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-82105482021-06-17 Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer Lin, Yung-Chang Cheng, Hsiao-Hsiang Chen, Shin-Cheh Shen, Wen-Chi Huang, Yi-Ting J Cancer Research Paper Background: Obesity is associated with poor prognosis in breast cancer patients. This study aimed to evaluate the effect of obesity measured by body mass index (BMI) on survival of Taiwanese breast cancer patients in a single institution. Methods: We observed 5000 patients who were diagnosed with stage I-III breast cancer between 1990 and 2005. Information on BMI at diagnosis, and clinical follow-up for disease recurrence and death, up to 20 years post-diagnosis were available. BMI (in kg/m(2)) categories included normal weight (BMI<24), overweight (24≤BMI<27), and obesity (BMI≥27), according to recommendations from the Bureau of Health Promotion of Taiwan. The role of BMI and other known prognostic factors for patient survival were evaluated in this patient cohort. Results: Obesity was associated with advanced stage, higher nuclear grade, and higher percentages of estrogen receptor (ER) positive. The median age of patients with a higher BMI was greater than the median age of patients with a lower BMI. Obesity was an independent prognostic factor of overall survival (OS) (P<0.001), but not disease-free survival (DFS) (P=0.067). We subsequently analyzed the impact of age-stratified BMI (age<50 and age≥50 years) to ameliorate the impact of age bias. Following subset analyses, obesity correlated with shorter DFS (P=0.004) and OS (P=0.009) only in women<50 years of age. Multivariate analysis revealed that BMI was an independent prognostic factor for both DFS and OS in this group of patients. Subset analysis revealed that in women <50 years old, the impact of BMI on survival was associated with higher stage, ER negativity. Conclusion: BMI is an independent prognostic factor of OS and DFS in breast cancer patients aged<50 years. Although the cause-effect relationship between obesity and survival is unclear, we recommend that weight control measures in young breast cancer survivors should be considered. Ivyspring International Publisher 2021-05-27 /pmc/articles/PMC8210548/ /pubmed/34149912 http://dx.doi.org/10.7150/jca.59133 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Lin, Yung-Chang
Cheng, Hsiao-Hsiang
Chen, Shin-Cheh
Shen, Wen-Chi
Huang, Yi-Ting
Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer
title Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer
title_full Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer
title_fullStr Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer
title_full_unstemmed Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer
title_short Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer
title_sort pre-treatment high body mass index is associated with poor survival in asian premenopausal women with localized breast cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210548/
https://www.ncbi.nlm.nih.gov/pubmed/34149912
http://dx.doi.org/10.7150/jca.59133
work_keys_str_mv AT linyungchang pretreatmenthighbodymassindexisassociatedwithpoorsurvivalinasianpremenopausalwomenwithlocalizedbreastcancer
AT chenghsiaohsiang pretreatmenthighbodymassindexisassociatedwithpoorsurvivalinasianpremenopausalwomenwithlocalizedbreastcancer
AT chenshincheh pretreatmenthighbodymassindexisassociatedwithpoorsurvivalinasianpremenopausalwomenwithlocalizedbreastcancer
AT shenwenchi pretreatmenthighbodymassindexisassociatedwithpoorsurvivalinasianpremenopausalwomenwithlocalizedbreastcancer
AT huangyiting pretreatmenthighbodymassindexisassociatedwithpoorsurvivalinasianpremenopausalwomenwithlocalizedbreastcancer